Article Information
History
- June 20, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Paolo Cifani1,*,
- Zhi Li2,3,*,
- Danmeng Luo1,*,
- Mark Grivainis2,
- Andrew M. Intlekofer4,
- David Fenyö2,3,** and
- Alex Kentsis1,5,**
- 1Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10021, USA
- 2Institute for Systems Genetics, NYU Grossman School of Medicine, New York, NY, 10016, USA
- 3Department of Biochemistry and Molecular Pharmacology, NYU Grossman School of Medicine, New York, NY, 10016, USA
- 4Human Oncology & Pathogenesis Program and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10021, USA
- 5Department of Pediatrics, Memorial Sloan Kettering Cancer Center, and Departments of Pediatrics, Pharmacology, and Physiology & Biophysics, Weill Medical College of Cornell University, New York, NY, 10021, USA
- ↵**Correspondence to: Alex Kentsis, kentsisresearchgroup{at}gmail.com and David Fenyö, David{at}FenyoLab.org
↵* These authors contributed equally: Paolo Cifani, Zhi Li, Danmeng Luo.
Posted June 20, 2020.
Discovery of protein modifications using high resolution differential mass spectrometry proteomics
